Sagebrush Allergy Shots (SCIT)
Sagebrush allergy shots (SCIT) use Artemisia tridentata extract to address the dominant aeroallergen across 165 million acres of Western US sage steppe — a plant clinically equivalent to mugwort due to greater-than-95% Art v 1 cross-reactivity, yet under-diagnosed when Eastern-focused weed panels skip A. tridentata. Pollen seasons are extending 13–20 days since 1990, and wildfire smoke synergistically worsens sagebrush-driven asthma across the Intermountain West.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Sagebrushis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Sagebrush Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to sagebrush — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of sagebrush allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of sagebrush immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of sagebrush extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for sagebrush allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing sagebrush extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription sagebrush immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat sagebrush allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Sagebrush?
The biology, taxonomy, and clinical fingerprint of Sagebrush — the foundation of how SCIT targets it.
Artemisia tridentata (big sagebrush) — tiny male pollen grains travel more than 100 miles by wind across Western rangeland, with peak airborne counts in late August
- Scientific name
- Artemisia tridentata
- Family
- AsteraceaeComposite / Daisy family
- Type
- Perennial native shrub pollen
- Native to
- Western North America — Great Basin, Intermountain West, northern High Plains
- Allergen proteins
- Art v 1 homologs (major — cross-reactive with A. vulgaris Art v 1; ≥95% amino acid identity)Art v 3 homologs (nsLTP — food cross-reactivity via mugwort-peach and celery-mugwort-spice pathways)Art v 4 homologs (profilin, pan-allergen)Art v 6 homologs (pectate lyase — cross-reacts with Amb p 1 in western ragweed)
- Particle size
- ~22 µm
- Avoidance difficulty
- Nearly impossible
How Sagebrush Allergy Presents
Symptoms by body system — useful for distinguishing Sagebrush sensitivity from overlapping allergies and infections.
Respiratory
- Late-summer rhinorrhea starting in early August across the Intermountain West
- Nasal congestion and sneezing during the August–September sagebrush peak
- Allergic asthma exacerbations compounded by simultaneous wildfire smoke exposure
- Prolonged upper-respiratory symptoms when pollen season is extended by climate change
- Exercise-induced bronchospasm during outdoor activities in sage steppe
Ocular
- Bilateral conjunctival redness and tearing during peak sagebrush counts
- Intense periocular itching
- Eyelid swelling on high-count days
- Photophobia in severe allergic conjunctivitis
Skin
- Oral tingling or lip swelling from raw celery, carrot, or chamomile (Art v 1 / Art v 4 cross-reactivity)
- Potential urticaria from stone fruit via Art v 3 LTP pathway (see mugwort brief for full food syndrome detail)
- Contact dermatitis from direct sagebrush plant handling (Compositae sesquiterpene lactone pathway)
- Atopic eczema flare during August–September pollen peak
Systemic
- Fatigue and sleep disruption from prolonged uncontrolled rhinitis during rangeland work
- Wildfire smoke and sagebrush pollen synergistic asthma exacerbation (Reid et al. 2016, Environ Health Perspect)
- Food-related systemic reactions possible in Art v 3-sensitized patients — full profile mirrors mugwort LTP syndrome
- Reduced work capacity for outdoor workers (ranchers, BLM crews, wildland firefighters) during August–September peak
Patients in Cheyenne, Boise, and Reno who fail intranasal steroids in August aren't necessarily failing because of ragweed — sagebrush is doing 60% of the work in the Intermountain West, and the diagnosis is missed when allergists order an East Coast weed panel that skips A. tridentata.
When & Where Sagebrush Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: late August through mid-September across the Intermountain West· ~10–12 weeks of pollen exposure; late July onset at some elevations, persisting into October
US Exposure Map
7 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Moderate
- MT:
- High
- ND:
- Moderate
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Low
- MA:
- Low
- OR:
- High
- ID:
- High
- WY:
- High
- SD:
- Moderate
- IA:
- Low
- IL:
- Low
- IN:
- Low
- OH:
- Low
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- Moderate
- NV:
- High
- UT:
- High
- CO:
- High
- NE:
- Moderate
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- Moderate
- NM:
- Moderate
- KS:
- Moderate
- AR:
- Low
- TN:
- Low
- NC:
- Low
- SC:
- Low
- OK:
- Low
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- Low
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Sagebrush Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Sagebrush shares the Artemisia Art v 1 allergen family with every other species in the genus, producing nearly complete IgE cross-reactivity; Art v 6 also cross-reacts with western ragweed's Amb p 1 pectate lyase, complicating late-summer differential diagnosis in the Great Basin and High Plains overlap zone.
Greater-than-95% Art v 1 amino acid identity — complete IgE cross-reactivity; mugwort is the molecular reference species for the genus
Multi-species Artemisia blends contain A. tridentata — clinically interchangeable with single-species sagebrush extract
Celery-mugwort-spice syndrome component via Art v 1 / Art v 4 (see mugwort page for full food syndrome detail)
Art v 4 profilin cross-reactivity; heat-labile, oral-itch pattern
Asteraceae family pan-allergen; chamomile tea can trigger oral symptoms in sagebrush-sensitized patients
Sagebrush and the Celery-Mugwort-Spice Pathway
Sagebrush sensitization produces the same celery-mugwort-spice cross-reactivity as mugwort, via shared Art v 1 and Art v 4 allergens. Patients with sagebrush rhinitis who notice oral tingling from raw celery, carrot, or chamomile tea may be experiencing Art v 4 profilin-mediated OAS. More severe food reactions — particularly to stone fruit or mustard — suggest Art v 3 LTP involvement; those patients need component-resolved testing and an epinephrine auto-injector.
Is SCIT Right for Your Sagebrush Allergy?
Answer five questions to estimate whether sagebrush SCIT is likely to be a strong, moderate, or limited option for your Western US fall allergy situation.
How severe are your late-summer / sagebrush-season symptoms in the Western US?
The Sagebrush SCIT Protocol
Sagebrush SCIT uses non-standardized Artemisia tridentata extract (W/V or PNU/mL labeled); no WHO/IUIS allergens are formally listed for A. tridentata, but Art v 1 homologs provide essentially complete genus-level coverage. Western US allergists often combine sagebrush in a fall-weed vial with Russian thistle and western ragweed to address the full Intermountain West pollen complex.
Extract concentration is escalated progressively; with Curex, trained Curex clinical staff supervise the first injection from each new vial or concentration live in the Virtual Shot Room and confirm a prescribed epinephrine auto-injector on hand. Starting the build-up in February–April allows reaching or approaching maintenance before the August peak. For ranchers and outdoor workers who cannot schedule weekly visits in summer, spring build-up is essential.
Once the target dose is reached, intervals extend to monthly. Symptom relief typically begins in the first treated season. The combined sagebrush + Russian thistle + ragweed vial common in Western practice addresses the overlapping August–October weed complex that patients in Nevada, Idaho, and Wyoming face simultaneously.
After successful completion, most patients maintain durable tolerance. Wildland firefighters and agricultural workers with ongoing high exposure may benefit from extended maintenance beyond 5 years. Re-sensitization can occur after stopping, particularly in areas where climate change is increasing sagebrush pollen loads.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Sagebrush SCIT
Sagebrush SCIT efficacy is supported by the broader Artemisia immunotherapy evidence base rather than A. tridentata-specific RCTs; Art v 1 cross-reactivity means trials conducted with A. vulgaris (mugwort) extract are clinically applicable to sagebrush-sensitized patients.
- Art v 1 IgE cross-reactivity across 9 Artemisia species95%Wopfner et al. 2008, Int Arch Allergy Immunol — ELISA inhibition confirms greater-than-95.4% amino acid identity across A. tridentata, A. vulgaris, and 7 additional species
- Symptom score reduction — Artemisia SCIT (A. vulgaris, applicable to A. tridentata)65%Tabar et al. 2005, Allergy — randomized trial N=48; 65% seasonal symptom score reduction at year 2, extrapolated to A. tridentata via Art v 1 cross-reactivity
- Season extension from climate change — Intermountain West18%Anderegg et al. 2021, PNAS — sagebrush pollen season extended an estimated 13–20 days in Northern Intermountain West stations since 1990, increasing cumulative exposure burden
No A. tridentata-specific SCIT RCT has been published. Clinical practice in Western US allergy extrapolates from A. vulgaris trials and from the documented greater-than-95% Art v 1 cross-reactivity across the genus. Available evidence supports meaningful symptom reduction over a 3–5 year course, consistent with the broader Artemisia immunotherapy data. Patients should discuss the extrapolation basis with their allergist when setting expectations.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Sagebrush SCIT Side Effects
Sagebrush SCIT side effects mirror the standard inhalant SCIT profile. Systemic reactions, when they occur, typically begin within about 30 minutes of an injection; with Curex, trained Curex clinical staff supervise the first injection from each new vial or concentration live in the Virtual Shot Room and confirm a prescribed epinephrine auto-injector on hand. Patients with concurrent asthma should have their peak flow checked before each injection.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Wheel-and-flare at injection site; resolves within 30–60 minutes | Rate 30–50% | Mild |
Injection-site itching | Rate 20–40% | Mild |
Injection-site redness | Rate 20–35% | Mild |
Large local reaction (>5 cm) Dose adjustment at next visit; not a reason to stop SCIT | Rate 5–10% | Moderate |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis/conjunctivitis flare | Rate 1–3% | Mild |
Generalized urticaria | Rate 0.1–0.5% | Moderate |
Mild asthma exacerbation Particularly relevant for wildland firefighters with combined smoke and pollen exposure | Rate 0.1–0.5% | Moderate |
Anaphylaxis Curex confirms a prescribed epinephrine auto-injector on hand and supervises the first injection from each new vial or concentration live in the Virtual Shot Room | Rate <0.01% per injection | Severe |
Sagebrush SCIT administered by a trained allergist with proper post-injection observation has an excellent safety record; systemic reactions are rare with appropriate pre-injection symptom screening and dose adjustment for patients with active asthma.
SCIT vs Alternatives for Sagebrush
Western US patients with sagebrush allergy have four main options: SCIT using A. tridentata extract (most disease-modifying evidence, requires clinic access), SLIT drops (at-home alternative well-suited to rural Western patients), avoidance (practically impossible in the sage steppe), or daily antihistamines and nasal steroids.
| Criterion | At-Home SCIT (Curex)Best | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | 65%+ symptom reduction (Tabar 2005, Artemisia extrapolation) | Moderate (extrapolated from Artemisia/grass data) | Minimal — pollen travels 100+ miles across open rangeland | Symptom suppression only |
| 5-yr cost | $3,500–$8,000 out-of-pocket | Daily drops (varies by pharmacy) | Low direct cost | $300–$1,200/year |
| Duration | 3–5 years | 3–5 years | Seasonal | Daily in season |
| Convenience | At-home self-injection; weekly then monthly | Daily drops at home — ideal for rural Western patients | Requires indoor confinement Aug–Sept | Convenient but daily burden |
| Safety | Systemic reaction <0.01%/injection | Lower systemic risk | Complete | Well-tolerated |
| Lasting effect | Durable — persists after stopping | Durable benefit expected | No lasting effect | No lasting effect |
At-Home SCIT (Curex)Best
SLIT
Avoidance
Medications
For ranchers, BLM crews, and wildland firefighters who cannot make weekly clinic visits during August sagebrush peak, Curex now delivers SCIT as an at-home allergy shot with pricing confirmed in a current program quote: a sagebrush serum compounded under USP <797>, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room, a prescribed epinephrine auto-injector confirmed on hand, and allergist-overseen escalation — combining sagebrush with Russian thistle and western ragweed in one personalized formulation, shipped to low-population Western ZIP codes.
What Sagebrush SCIT Actually Costs
Sagebrush SCIT is typically covered under standard allergy immunotherapy benefits when ordered by a board-certified allergist with documented sensitization via skin prick test or specific IgE; coverage varies by plan deductible and co-insurance. Curex at-home IgE testing identifies specific sagebrush sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your sagebrush allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Sagebrush SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Sagebrush sensitization is missed when allergists use Eastern US-oriented weed panels that include short ragweed, mugwort, and marsh elder but omit Artemisia tridentata. In the Intermountain West, sagebrush can account for the majority of the late-summer pollen burden, but if it isn't on the test panel, the patient receives a false-negative result and incorrect guidance. Regional allergy panels tailored to the Western flora — including A. tridentata, Russian thistle, western ragweed, and kochia — are essential for accurate diagnosis in states like Nevada, Idaho, Wyoming, and Utah. Requesting a Western US-specific weed panel is appropriate for any patient presenting with August–October symptoms in these states.
Functionally yes — because Art v 1 sequence identity exceeds 95% across all Artemisia species studied, IgE raised against sagebrush (A. tridentata) recognizes mugwort (A. vulgaris) extract and vice versa. This means a patient confirmed as sagebrush-sensitized is also mugwort-sensitized, and either extract will cover the full genus in SCIT. The practical clinical difference is regional preference: Western US allergists prescribe sagebrush extract because it reflects local flora, while Eastern US allergists prescribe mugwort. Patients who travel between regions or relocate don't need to change extracts — the cross-reactivity is complete.
Yes — published research (Reid et al. 2016, Environ Health Perspect) documents that simultaneous wildfire smoke and sagebrush pollen exposure synergistically worsens asthma outcomes in Western US populations. Smoke particles can carry pollen fragments deeper into airways, amplify airway inflammation, and reduce mucociliary clearance. During August wildfire events in the Pacific Northwest, Interior West, and Rocky Mountain states, patients with sagebrush allergy and concurrent asthma face compounded risk. This is one reason allergists may recommend initiating SCIT early in the sagebrush allergy course rather than waiting for symptoms to become severe — each fire season can produce a step-change in sensitization.
A board-certified allergist typically recommends beginning the sagebrush SCIT build-up at least 12 weeks before the anticipated August onset — meaning a spring start in late April or May is ideal. This timing allows reaching or approaching the maintenance dose before peak exposure, maximizing first-season benefit. For ranchers and outdoor workers who cannot schedule weekly visits in summer, a pre-season spring build-up schedule is critical. Even starting in June can produce partial first-season benefit if the build-up is accelerated appropriately under allergist guidance.
Sagebrush SCIT specifically targets the Artemisia Art v 1 allergen family — it does not directly desensitize Russian thistle (Salsola kali, Sal k 1 pectin methylesterase) or western ragweed (Ambrosia psilostachya, Amb p 5). These are distinct allergen families with different protein structures. However, Western US allergists routinely combine sagebrush with Russian thistle and western ragweed extracts in a single fall-weed vial, so a patient receiving a Western weed vial is simultaneously building tolerance to all three. Discussing a combined vial approach with your allergist is standard practice for the Intermountain West fall pollen complex.
Sagebrush (A. tridentata) SCIT is typically covered under standard allergy immunotherapy benefits when ordered by a board-certified allergist with documented sensitization via skin prick test or specific IgE. Coverage applies to extract preparation (CPT 95165) and injection administration (CPT 95115 or 95117). Non-standardization of the sagebrush extract does not typically affect coverage determination. Out-of-pocket costs depend heavily on plan deductible and co-insurance; patients in high-deductible plans may face a portion of the first-year cost until the deductible is met. Confirming benefits and prior authorization requirements before starting is recommended.
Sagebrush (Artemisia tridentata) and culinary sage (Salvia officinalis) are completely unrelated plants from different families. Sagebrush is an Asteraceae wind-pollinated native shrub and a major respiratory allergen. Culinary sage is a Lamiaceae insect-pollinated herb that is not a significant aeroallergen — its clinical relevance is as a contact allergen via terpene-rich essential oils (Type IV mechanism), not as a cause of hay fever. The naming confusion is widespread and clinically consequential: patients sometimes request sagebrush shots after a reaction to cooking with sage, but that reaction requires entirely different evaluation. If you react to handling or consuming culinary sage, an allergist should investigate Type IV contact allergy and food intolerance pathways, not Artemisia IgE testing.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.